Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis in Gulf Countries

NCT07467564 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT07467564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07467564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis in Gulf Countries
Lead sponsor
Sanofi
Phase
Observational
Overall status
Recruiting
Start date
February 24, 2026
Completion date
May 24, 2027
Enrollment
184 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis